Prime Capital Investment Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Sell |
2,871
-1,127
| -28% | -$88.1K | ﹤0.01% | 860 |
|
|
2025
Q1 | $290K | Buy |
+3,998
| New | +$290K | ﹤0.01% | 849 |
|
|
2024
Q3 | – | Sell |
-3,862
| Closed | -$357K | – | 923 |
|
|
2024
Q2 | $357K | Sell |
3,862
-1,720
| -31% | -$159K | 0.01% | 672 |
|
|
2024
Q1 | $533K | Buy |
5,582
+229
| +4% | +$21.9K | 0.01% | 605 |
|
|
2023
Q4 | $408K | Buy |
5,353
+1,331
| +33% | +$101K | 0.01% | 630 |
|
|
2023
Q3 | $279K | Buy |
4,022
+84
| +2% | +$5.82K | 0.01% | 608 |
|
|
2023
Q2 | $371K | Buy |
+3,938
| New | +$371K | 0.01% | 543 |
|
|
2023
Q1 | – | Sell |
-3,381
| Closed | -$252K | – | 575 |
|
|
2022
Q4 | $252K | Buy |
+3,381
| New | +$252K | 0.01% | 450 |
|
|
2018
Q4 | – | Sell |
-2,115
| Closed | -$123K | – | 372 |
|
|
2018
Q3 | $123K | Buy |
2,115
+1,803
| +578% | +$105K | 0.04% | 147 |
|
|
2018
Q2 | $15K | Buy |
+312
| New | +$15K | 0.01% | 256 |
|